Symbol="VIR"
AssetType="Common Stock"
Name="Vir Biotechnology Inc"
Description="Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California."
CIK="1706431"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3080131000"
EBITDA="-276062016"
PERatio="None"
PEGRatio="None"
BookValue="14.71"
DividendPerShare="0"
DividendYield="0"
EPS="-1.02"
RevenuePerShareTTM="3.356"
ProfitMargin="-0.322"
OperatingMarginTTM="-0.643"
ReturnOnAssetsTTM="-0.0646"
ReturnOnEquityTTM="-0.0724"
RevenueTTM="446295000"
GrossProfitTTM="1032030000"
DilutedEPSTTM="-1.02"
QuarterlyEarningsGrowthYOY="0.585"
QuarterlyRevenueGrowthYOY="-0.949"
AnalystTargetPrice="49.71"
TrailingPE="-"
ForwardPE="4.361"
PriceToSalesRatioTTM="1.409"
PriceToBookRatio="1.604"
EVToRevenue="0.52"
EVToEBITDA="0.789"
Beta="0.197"
num_52WeekHigh="31.78"
num_52WeekLow="18.05"
num_50DayMovingAverage="25.23"
num_200DayMovingAverage="24.76"
SharesOutstanding="133977000"
DividendDate="None"
ExDividendDate="None"
symbol="VIR"
open="22.82"
high="23.38"
low="22.80"
price="22.99"
volume="731949.00"
latest_trading_day="2023-07-07"
previous_close="22.84"
change="0.15"
change_percent="0.6567%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="62"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="969040"
Change_recent_avg="-0.02"
Delta_recent_avg="0.88"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="169"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_negative_thumbnail_id_2="101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="955"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_positive_thumbnail_id_2="995"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0157.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
